Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial - Goldschmidt, Hartmut; Mai, Elias K.; Hose, Dirk; Jauch, Anna; Hillengaß, Jens; Raab, Marc-Steffen; Bertsch, Uta; Hielscher, Thomas (Leukemia, 2018)
Published: 04 July 2017
Gesehen am 20.09.2018